These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 15596441

  • 1. Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway.
    Grace MJ, Lee S, Bradshaw S, Chapman J, Spond J, Cox S, Delorenzo M, Brassard D, Wylie D, Cannon-Carlson S, Cullen C, Indelicato S, Voloch M, Bordens R.
    J Biol Chem; 2005 Feb 25; 280(8):6327-36. PubMed ID: 15596441
    [Abstract] [Full Text] [Related]

  • 2. Pegylating IFNs at his-34 improves the in vitro antiviral activity through the JAK/STAT pathway.
    Grace MJ, Cutler D.
    Antivir Chem Chemother; 2004 Nov 25; 15(6):287-97. PubMed ID: 15646642
    [Abstract] [Full Text] [Related]

  • 3. Structural and biologic characterization of pegylated recombinant IFN-alpha2b.
    Grace M, Youngster S, Gitlin G, Sydor W, Xie L, Westreich L, Jacobs S, Brassard D, Bausch J, Bordens R.
    J Interferon Cytokine Res; 2001 Dec 25; 21(12):1103-15. PubMed ID: 11798469
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.
    Ramon J, Saez V, Baez R, Aldana R, Hardy E.
    Pharm Res; 2005 Aug 25; 22(8):1374-86. PubMed ID: 16078148
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers to the extracellular domain of the receptor IFNAR2.
    Dhalluin C, Ross A, Huber W, Gerber P, Brugger D, Gsell B, Senn H.
    Bioconjug Chem; 2005 Aug 25; 16(3):518-27. PubMed ID: 15898717
    [Abstract] [Full Text] [Related]

  • 12. Identification of the major positional isomer of pegylated interferon alpha-2b.
    Wang YS, Youngster S, Bausch J, Zhang R, McNemar C, Wyss DF.
    Biochemistry; 2000 Sep 05; 39(35):10634-40. PubMed ID: 10978146
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic.
    Bell SJ, Fam CM, Chlipala EA, Carlson SJ, Lee JI, Rosendahl MS, Doherty DH, Cox GN.
    Bioconjug Chem; 2008 Jan 05; 19(1):299-305. PubMed ID: 18020402
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A new method to produce monoPEGylated dimeric cytokines shown with human interferon-α2b.
    Chang CH, Rossi EA, Cardillo TM, Nordstrom DL, McBride WJ, Goldenberg DM.
    Bioconjug Chem; 2009 Oct 21; 20(10):1899-907. PubMed ID: 19736932
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biological characterization of pegylated interferons: a case study.
    Xie L, Cullen C, Bradshaw S, DeLorenzo M, Grace MJ.
    Methods Mol Biol; 2005 Oct 21; 308():319-35. PubMed ID: 16082045
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.